✦ LIBER ✦

Treatment of chronic hepatitis C patients with Acyclovir

Book ID: 118566815
Publisher: Elsevier Science
Year: 1994
Tongue: English
Weight: 101 KB
Volume: 21
Category: Article
ISSN: 0168-8278
DOI: 10.1016/s0168-8278(05)81011-6

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Treatment of chronic HBeAg-positive hepa

Treatment of chronic HBeAg-positive hepatitis with acyclovir

✍ Guarascio, Paolo; De Felici, Anna Paola; Migliorini, Daniela; Alexander, Graeme 📂 Article 📅 1986 🏛 Elsevier Science 🌐 English ⚖ 320 KB

Treatment of chronic hepatitis C patient

Treatment of chronic hepatitis C patients with amantadine

✍ Michiyasu Yagura; Hideharu Harada 📂 Article 📅 2001 🏛 Springer Japan 🌐 English ⚖ 76 KB

Treatment of naive patients with chronic

Treatment of naive patients with chronic hepatitis C

✍ Ola Weiland 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 658 KB

Treatment of patients with chronic hepat

Treatment of patients with chronic hepatitis C and cirrhosis

✍ F. Bonino; f. Oliveri; P. Colombatto; B. Coco; D. Mura; G. Realdi; M.R. Brunetto 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 551 KB

Re-treatment with interferon alfa of pat

Re-treatment with interferon alfa of patients with chronic hepatitis C

✍ Wan-Cheng Chow; Nathalie Boyer; Michele Pouteau; Corinne Castelnau; Michele Mart 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 95 KB 👁 2 views

Treatment of patients with chronic hepatitis C has had limited success because of relapses and nonresponse to interferon alfa therapy (currently the only established therapeutic agent). A retrospective study was done to determine the efficacy of re-treatment with interferon and the predictors of res

Treatment of chronic non-A, non-B hepati

Treatment of chronic non-A, non-B hepatitis with acyclovir: Pilot study

✍ S. Chris Pappas; Dr. Jay H. Hoofnagle; Neal Young; Stephen E. Straus; E. Anthony 📂 Article 📅 1985 🏛 John Wiley and Sons 🌐 English ⚖ 576 KB

Five patients with chronic non-A, non-B hepatitis were entered into a pilot therapeutic study of the antiviral agent acyclovir [9-(2-hydroxyethoxymethyl) guanine]. Each patient received acyclovir by slow intravenous infusion in a dosage of 5 mg/kg every 8 hr for 10 days. During therapy, serum aminot